Gene Expression Changes in Alzheimer's Disease
Author Information
Author(s): Miller Miles C, Stopa Edward G, Nikonova Elena V, Tanis Keith Q, Podtelezhnikov Alexei A, Finney Eva M, Stone David J, Camargo Luiz M, Parker Lisan, Verma Ajay, Baird Andrew, Donahue John E, Gonzalez Ana Maria, Eliceiri Brian, Silverberg Gerald D, Klinge Petra M, Johanson Conrad E
Primary Institution: Rhode Island Hospital, The Warren Alpert Medical School, Brown University
Hypothesis
Alterations in choroid plexus gene expression are associated with changes in cerebrospinal fluid (CSF) composition in Alzheimer's disease.
Conclusion
The study found significant differences in gene expression in the choroid plexus of Alzheimer's patients compared to controls, indicating potential biomarkers for disease.
Supporting Evidence
- Gene expression differences were significant in Alzheimer's patients compared to healthy controls.
- Nearly fifty percent of the analyzed sequences were up-regulated in neurodegenerative disease states.
- Immune response was significantly increased in advanced Alzheimer's patients.
- Amyloid processing and oxidative phosphorylation were down-regulated in Alzheimer's cases.
- Cellular adhesion function and extracellular matrix remodeling were enriched in advanced Alzheimer's patients.
Takeaway
Researchers looked at brain tissue from people with Alzheimer's and found changes in genes that might help us understand how the disease affects brain fluid.
Methodology
Choroid plexuses were excised from autopsy samples and analyzed using gene arrays and one way ANOVA.
Participant Demographics
Healthy aged controls (mean age 58 years) and patients with advanced Alzheimer's disease (mean age 79 years).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website